Navigation Links
Robbins Arroyo LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Hemispherx Biopharma, Inc.
Date:1/17/2013

proval for Ampligen, the FDA noted that "[i]t would be unusual for this type of data to provide adequate evidence of efficacy."

Upon review of the post-hoc analyses, on December 18, 2012, the FDA released a report citing that the additional information submitted by the Company was insufficient. The report further stated that the Company's studies were "ill-defined and invalid," noting inconsistencies regarding the effectiveness and finding nine potential safety concerns. As a result of this news, Hemispherx shares declined $0.276 per share, or approximately 43%, closing at $.368 per share on December 18, 2012.

If you purchased or otherwise acquired Hemispherx stock during the Class Period and wish to serve as lead plaintiff, you must act no later than February 22, 2013.  To discuss your shareholder rights, please contact attorney Darnell R. Donahue at (800) 350-6003, inquiry@robbinsarroyo.com, or via the shareholder information form on the firm's website. 

Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law.  The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.  For more information, please go to http://www.robbinsarroyo.com.

Press release link: http://www.robbinsarroyo.com/shareholders-rights-blog/hemispherx-biopharma-inc/

Attorney Advertising. Past results do not guarantee a similar outcom
'/>"/>

SOURCE Robbins Arroyo LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Robbins Umeda LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Abiomed, Inc.
2. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
3. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
4. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
5. Misonix Announces New Distribution Agreement For Panama
6. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
7. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
8. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
9. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
10. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
11. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... März 2015 Unfors RaySafe, ... Bereich diagnostische Röntgenstrahlung, stellte heute auf ... European Congress of Radiology (ECR) in ... einen neuen Strahlungsüberwachungssensor vor. ... Der RaySafe X2-Überwachungssensor stellt ...
(Date:3/4/2015)... 4, 2015  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... of the Phase II proof of concept clinical ... as a monotherapy in the treatment of chronic ... highly significant and clinically meaningful improvement from baseline ... measured on a 100mm unit Visual Analog Scale ...
(Date:3/4/2015)... Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the ... China, today announced its financial results for the fourth ... Quarter 2014 Financial Highlights , Total sales ... or 36.8% excluding the impact of foreign currency exchange ... the same quarter of 2013. , Gross profit ...
Breaking Medicine Technology:Unfors RaySafe, ein Unternehmen von Fluke Biomedical, stellt auf European Congress of Radiology neuen Überwachungssensor vor 2Unfors RaySafe, ein Unternehmen von Fluke Biomedical, stellt auf European Congress of Radiology neuen Überwachungssensor vor 3Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 3Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 4Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 5Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 6Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 7China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 2China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 3China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 4China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 5China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 6China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 7China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 8China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 9China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 10China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 11China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 12China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 13China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 14China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 15China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 16China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 17China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 18China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 19China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 20China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 21China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 22
... SPRING, Md., Oct. 14 The Food and ... ,chelation, products—which claim to treat everything from autism ... metals. (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... On Thursday, the agency warned eight companies ...
... The U.S. Health and ... (ASPE) has selected Thomson Reuters to develop a ... perform comparative effectiveness studies without the need for ... ) (Logo: http://www.newscom.com/cgi-bin/prnh/20090507/NY12658LOGO ) ...
Cached Medicine Technology:Federal Government Selects Thomson Reuters to Build Tool That Streamlines Comparative Effectiveness Research 2
(Date:3/5/2015)... March 05, 2015 Colorful packaging and ... cereals are best for health. But all it really ... to look for, reports the March 2015 Harvard ... plan," says Kathy McManus, director of the Department of ... a cereal that hits all the markers of good ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Considering egg ... fertility practice, is holding an informational event ... proactively plan for future families with egg freezing. , ... Plaza, 3500 Peachtree Rd, Atlanta, GA, Time: 5:30 - ... but RSVP required. Register here ! , In ...
(Date:3/5/2015)... 05, 2015 Hope For The Warriors® is ... Shoot to be held at Beretta Shooting Grounds (Dover Furnace) ... proceeds from the event will benefit Hope For The Warriors®, ... restoring the family unit, and restoring hope for our service ... our nation’s heroes through a day of clay shooting at ...
(Date:3/5/2015)... Omaha, NE (PRWEB) March 05, 2015 ... healthcare staffing, including locum tenens and direct hire physician ... exhibitor at the Nebraska Academy of Family Physicians 67th ... 19-21, 2015 in La Vista, Nebraska. , The ... new ways to learn, networking opportunities, and an exhibition ...
(Date:3/5/2015)... 2015 The pleasing melodies of live bluegrass ... of America bicycle and hand cycle ride as they arrive ... Flower Hill String Band will present a free concert ... from the Pentagon in Arlington, Virginia. , “We are thrilled ... “These folk have sacrificed so much. We love being to ...
Breaking Medicine News(10 mins):Health News:Tips to Find the Healthiest Breakfast Cereals, From the March 2015 Harvard Health Letter 2Health News:Egg Freezing Seminar Allows Women to Pause the Biological Clock for Age, Social or Medical Reasons 2Health News:Egg Freezing Seminar Allows Women to Pause the Biological Clock for Age, Social or Medical Reasons 3Health News:Hope For The Warriors Announces New York Clay Shoot to Benefit Military Families 2Health News:Healthcare Staffing Agency, Aureus Medical Group, to Exhibit at the Nebraska Academy of Family Physicians Annual Meeting & Scientific Assembly 2Health News:Flower Hill String Band to Welcome Face of America with Bluegrass Music 2Health News:Flower Hill String Band to Welcome Face of America with Bluegrass Music 3
... of George Washington University, while presenting a paper at the ... size pieces and cooking them to into mashed textures may ... crooked and badly formed. Thus congenital bad shaped teeth may ... ,Human teeth are in bad shape, when compared with ...
... Researchers say women treated with the anti-estrogen drug tamoxifen (Nolvadex) ... experience symptoms of heart stress, such as angina. Tamoxifen is ... cancer. The drug has been shown to reduce the risk ... ,Researchers conducted a study to evaluate whether tamoxifen reduces ...
... effects of epidural pain relief on caesarian delivery, it was ... labor does not increase the incidence of caesarian delivery. ... the study. All were delivering for the first time. When ... early stages of labor tended to be in labor for ...
... latest study researchers say a simple drug might have the ... malaria// do not ever make it to a hospital. For ... the deaths occur within the first day of admission. ... to administer outside of a hospital. In order to more ...
... in carrots may reduce the risk of developing cancer. ... natural pesticide found in carrots, is the specific component ... protects carrots from fungal diseases, such as licorice rot, ... Researchers suspected falcarinol is effective because it stimulates mechanisms ...
... the recent Journal of American Dental Association (JADA), doctors ... fluoride dosage //to patients with oral problems. ... patients to check caries, especially those suffering from mouth ... C. Eichmiller, Naomi Eidelman, and Clifton M. Carey have ...
Cached Medicine News:
The removable inflation adapter allows the ureteroscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
Radiopaque markers are placed at the proximal and distal ends of the balloon. A special pin vise handle is included to stabilize the wire guide during introduction. Supplied sterile in peel-open pack...
... new AquaGuide Ureteral Access Sheath, you can ... access sheath - plus an entirely new ... sheath is designed with a proprietary dual ... second working channel for a variety of ...
Used retrograde to dilate the ureter and establish a conduit for a flexible ureteroscope. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: